Renaissance of the Biologically Active Vitamin A Derivatives: Established and Novel Directed Therapies for Cancer and Chemoprevention
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2067-2077
Author(s):
J. Brtko and J. Thalhamer
CB 1954: From the Walker Tumor to NQO2 and VDEPT
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2091-2104
Author(s):
Richard J. Knox, Philip J. Burke, Shiuan Chen and David J. Kerr
Preface
Journal:
Current Molecular Medicine
Volume:
3
Page:
i-i
Author(s):
Xiao-Ming Yin
Gene Therapy of Cancer with Interleukin-12
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1981-1991
Author(s):
Guillermo Mazzolini, Jesus Prieto and Ignacio Melero
Exploiting New Potential Targets for Anti-Hepatitis B Virus Drugs
Journal:
Current Drug Targets - Infectious Disorders
Volume:
3
Page:
241-246
Author(s):
Y-M Wen, X Lin and Z-M Ma
Molecular Therapeutics of HBV
Journal:
Current Gene Therapy
Volume:
3
Page:
341-355
Author(s):
Ruian Xu, Kexia Cai, Dexian Zheng, Hong Ma, Sue Xu and Sheung-tat Fan
Tamoxifen: Is it Safe? Comparison of Activation and Detoxication Mechanisms in Rodents and in Humans
Journal:
Current Drug Metabolism
Volume:
4
Page:
223-239
Author(s):
I. N.H. White
Peroxisome Proliferator Activated Receptor-Gamma Ligands as Potent Antineoplastic Agents
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
239-251
Author(s):
S. Theocharis, A. Margeli and G. Kouraklis
From TGF-β to Cancer Therapy
Journal:
Current Drug Targets
Volume:
4
Page:
243-250
Author(s):
Xuemei Huang and Chung Lee
The Prodigiosins: A New Family of Anticancer Drugs
Journal:
Current Cancer Drug Targets
Volume:
3
Page:
57-65
Author(s):
Beatriz Montaner and Ricardo Pérez-Tomás